Ameritas Investment Partners, Inc. Aveo Pharmaceuticals, Inc. Call Options Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AVEO
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About AVEO PHARMACEUTICALS, INC.
- Ticker AVEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,676,000
- Description
- AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...